ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

From Avigan to remdesivir, hopes run high for coronavirus drugs

Scientists warn even repurposed medications will take time to show efficacy

Clinical trials to test the effectiveness of Avigan, made by Fujifilm of Japan, against the new coronavirus, will begin next week, the company says.   © Reuters

TOKYO -- As the novel coronavirus continues to spread, wreaking havoc on the global economy, drugmakers around the world are searching for treatments and vaccines to stop the disease in its tracks.

Scientists are hopeful that treatments and vaccines are on the way, but they caution against promises of a quick fix.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more